News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,148 Results
Type
Article (69233)
Company Profile (463)
Press Release (646428)
Multimedia
Podcasts (184)
Webinars (28)
Section
Business (180796)
Career Advice (3244)
Deals (32162)
Drug Delivery (141)
Drug Development (82974)
Employer Resources (181)
FDA (16066)
Job Trends (14362)
News (318872)
Policy (30870)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2978)
Academic (1)
Accelerated approval (46)
Adcomms (37)
Allergies (172)
Alliances (48847)
ALS (211)
Alzheimer's disease (1887)
Antibody-drug conjugate (ADC) (462)
Approvals (16345)
Artificial intelligence (680)
Autoimmune disease (269)
Automation (50)
Bankruptcy (308)
Best Places to Work (11373)
BIOSECURE Act (19)
Biosimilars (214)
Biotechnology (321)
Bladder cancer (187)
Brain cancer (76)
Breast cancer (743)
Cancer (5815)
Cardiovascular disease (492)
Career advice (2769)
Career pathing (47)
CAR-T (345)
CDC (62)
Celiac Disease (2)
Cell therapy (936)
Cervical cancer (43)
Clinical research (71013)
Collaboration (2149)
Company closure (7)
Compensation (1275)
Complete response letters (96)
COVID-19 (2844)
CRISPR (112)
C-suite (1063)
Cystic fibrosis (161)
Data (7601)
Decentralized trials (3)
Denatured (58)
Depression (179)
Dermatology (72)
Diabetes (581)
Diagnostics (6584)
Digital health (54)
Diversity (11)
Diversity, equity & inclusion (44)
Drug discovery (343)
Drug pricing (207)
Drug shortages (36)
Duchenne muscular dystrophy (291)
Earnings (71646)
Editorial (74)
Employer branding (23)
Employer resources (161)
Events (117259)
Executive appointments (1045)
FDA (19663)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1745)
Gene editing (240)
Generative AI (69)
Gene therapy (774)
GLP-1 (1134)
Government (4899)
Grass and pollen (7)
Guidances (388)
Healthcare (19116)
HIV (83)
Huntington's disease (56)
IgA nephropathy (98)
Immunology and inflammation (319)
Immuno-oncology (96)
Indications (165)
Infectious disease (3188)
Inflammatory bowel disease (224)
Inflation Reduction Act (16)
Influenza (135)
Intellectual property (281)
Interviews (633)
IPO (15404)
IRA (56)
Job creations (3341)
Job search strategy (2238)
JPM (71)
Kidney cancer (18)
Labor market (95)
Layoffs (589)
Leadership (47)
Legal (6600)
Liver cancer (94)
Longevity (28)
Lung cancer (768)
Lymphoma (423)
Machine learning (58)
Management (63)
Manufacturing (1009)
MASH (194)
Medical device (12867)
Medtech (12948)
Mergers & acquisitions (17987)
Metabolic disorders (1548)
mRNA (226)
Multiple sclerosis (185)
NASH (22)
Neurodegenerative disease (430)
Neuropsychiatric disorders (118)
Neuroscience (3437)
Neurotech (1)
NextGen: Class of 2026 (6634)
Non-profit (4770)
Now hiring (67)
Obesity (738)
Opinion (354)
Ovarian cancer (211)
Pain (260)
Pancreatic cancer (284)
Parkinson's disease (368)
Partnered (36)
Patents (565)
Patient recruitment (648)
Peanut (64)
People (55409)
Pharmaceutical (79)
Pharmacy benefit managers (32)
Phase 1 (22261)
Phase 2 (31244)
Phase 3 (23210)
Pipeline (7750)
Policy (353)
Postmarket research (2716)
Preclinical (10024)
Press Release (71)
Prostate cancer (299)
Psychedelics (64)
Radiopharmaceuticals (340)
Rare diseases (1133)
Real estate (5834)
Recruiting (77)
Regulatory (24695)
Reports (47)
Research institute (2728)
Resumes & cover letters (512)
Rett syndrome (35)
RNA editing (25)
RSV (90)
Schizophrenia (182)
Series A (292)
Series B (215)
Service/supplier (15)
Sickle cell disease (117)
Special edition (30)
Spinal muscular atrophy (181)
Sponsored (53)
Startups (3547)
State (2)
Stomach cancer (20)
Supply chain (126)
Tariffs (87)
The Weekly (124)
Vaccines (1128)
Venture capital (110)
Weight loss (500)
Women's health (110)
Worklife (24)
Date
Last 7 days (755)
Last 30 days (2545)
Last 365 days (30935)
2026 (10027)
2025 (31005)
2024 (35757)
2023 (40226)
2022 (51276)
2021 (55601)
2020 (53507)
2019 (46402)
2018 (35101)
2017 (32648)
2016 (32506)
2015 (37736)
2014 (30366)
2013 (26331)
2012 (27203)
2011 (27650)
2010 (25983)
Location
Africa (1001)
Alabama (99)
Alaska (7)
Arizona (286)
Arkansas (16)
Asia (42468)
Australia (7672)
California (12558)
Canada (3589)
China (1361)
Colorado (536)
Connecticut (550)
Delaware (377)
Europe (99676)
Florida (1873)
Georgia (401)
Hawaii (3)
Idaho (59)
Illinois (1016)
India (92)
Indiana (551)
Iowa (25)
Japan (518)
Kansas (131)
Kentucky (44)
Louisiana (41)
Maine (63)
Maryland (1500)
Massachusetts (9289)
Michigan (346)
Minnesota (689)
Mississippi (4)
Missouri (148)
Montana (34)
Nebraska (26)
Nevada (128)
New Hampshire (82)
New Jersey (3377)
New Mexico (32)
New York (3349)
North Carolina (1655)
North Dakota (9)
Northern California (6212)
Ohio (379)
Oklahoma (24)
Oregon (41)
Pennsylvania (2542)
Puerto Rico (24)
Rhode Island (49)
South America (1293)
South Carolina (81)
South Dakota (1)
Southern California (4941)
Tennessee (174)
Texas (1967)
United States (44813)
Utah (356)
Vermont (1)
Virginia (303)
Washington D.C. (77)
Washington State (1050)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
716,148 Results for "the lupus research alliance".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lupus Therapeutics, the Clinical Affiliate of the Lupus Research Alliance, Broadens Proven Peer-to-Peer Program in Clinical Trials
February 24, 2026
·
4 min read
Press Releases
Lupus Research Alliance Launches New Philanthropic Fund to Advance Treatments and Diagnostics
January 6, 2026
·
5 min read
Press Releases
Lupus Research Alliance Funds Study to Understand Connection between the Common Epstein-Barr Virus and Lupus
November 13, 2025
·
3 min read
Press Releases
Lupus Research Alliance Showcases Research that will Shape Next Generation Treatments at ACR Convergence 2025
October 22, 2025
·
8 min read
Press Releases
Progentec Diagnostics Advances Ability to Determine Lupus Risk with New Research and OCAST Grant
April 10, 2026
·
2 min read
Immunology and Inflammation
Biogen’s Lupus Drug Reduces Disease Activity, Further Deresking I&I Pipeline
William Blair hailed a positive readout in cutaneous lupus erythematosus as a turning point for Biogen, while RBC Capital analysts called the results “another derisking step” for the company’s immunology and inflammation pipeline.
March 30, 2026
·
4 min read
·
Heather McKenzie
Autoimmune disease
Cabaletta’s CAR T Therapy Spurs Remissions in Small Lupus Trial
Phase I/II data for rese-cel point to its therapeutic potential in systemic lupus erythematosus and lupus nephritis, as well as other autoimmune conditions.
October 28, 2025
·
2 min read
·
Tristan Manalac
Business
Lupus Research Alliance Awards Lupus Insight Prize to Two Trailblazers in CAR T Cell Therapy
The Lupus Research Alliance announced the recipients of the 2024 Lupus Insight Prize to Marko Radic, Ph.D., The University of Tennessee Health Science Center, and Georg Schett, M.D., Friedrich-Alexander-Universität Erlangen-Nürnberg, for their groundbreaking discoveries in utilizing CAR T cell therapy to potentially revolutionize lupus treatment.
June 20, 2024
·
6 min read
Press Releases
Lupus Research Alliance Grants Lupus Innovation Awards to Eleven Talented Researchers to Accelerate Pace of Discovery in Lupus Research
April 16, 2025
·
7 min read
Press Releases
Lupus Research Alliance Grants Inaugural Awards to 11 Researchers Focused on Engineered Cell Therapies for Lupus
March 20, 2025
·
8 min read
1 of 71,615
Next
